Estrogen Supplementation and Bone Health in Women With CF
Phase 4
75
about 3.8 years
0–100
Female only
1 site in MD
What this study is about
Researchers are testing whether estrogen supplementation, including transdermal estrogen patches, affects bone health in women with cystic fibrosis. The trial also explores the feasibility of using transdermal estrogen and compares different forms of hormonal contraception on bone health. Participants will have their hormone levels, bone density, and quality of life assessed over time.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Progesterone
- 2.Take Transdermal estrogen
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
progesterone (Progestin hormone; prepares uterus lining), Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) (Estrogen Receptor Agonists)
oral (Oral Capsule), transdermal
Secondary: Change in quality of life as assessed by Cystic Fibrosis Respiratory Symptom Diary - Chronic Respiratory Infection Symptom Score (CFRSD-CRISS) questionnaire
Respiratory